Autocrine VEGF and IL-8 Promote Migration Via Src/Vav2/Rac1/PAK1 Signaling in Human Umbilical Vein Endothelial Cells
Overview
Cell Biology
Pharmacology
Authors
Affiliations
Background/aims: Pro-angiogenic factors VEGF and IL-8 play a major role in modulating the migratory potential of endothelial cells. The goal of this study was to investigate the effect of autocrine VEGF and IL-8 in the form of self-conditioned medium (CM) on human umbilical vein endothelial cells (HUVECs).
Methods: Enzyme-linked immunosorbent assay (ELISA) examined the automatic secretion of VEGF and IL-8 protein by HUVECs. Western blot, small interfering RNA (siRNA), pulldown and Transwell assays were used to explore the role and the mechanism of autocrine VEGF and IL-8 in migration of HUVECs.
Results: Neutralizing VEGF and IL-8 in CM significantly abrogated CM-induced migration of HUVECs. Autocrine VEGF and IL-8 increased Src phosphorylation, Rac1 activity and PAK1 phosphorylation in a time dependent manner. Additionally, blocking Rac1 activity with Rac1 siRNA largely abolished autocrine VEGF and IL-8-induced cell migration. Vav2 siRNA suppressed autocrine VEGF and IL-8-induced Rac1 activation and cell migration. Furthermore, blocking Src signaling with PP2, a specific inhibitor for Src, markedly prevented autocrine VEGF and IL-8-induced Vav2 and Rac1 activation as well as consequently cell migration. PAK1 siRNA also significantly abolished autocrine VEGF and IL-8-induced cell migration.
Conclusions: We demonstrated for the first time that autocrine VEGF and IL-8 promoted endothelial cell migration via the Src/Vav2/Rac1/PAK1 signaling pathway. This finding reveals the molecular mechanism in the increase of endothelial cell migration induced by autocrine growth factors and cytokines, which is expected to provide a novel therapeutic target in vascular diseases.
Kawamura J, Yamakuchi M, Ueno K, Hashiguchi T, Okamoto Y Sci Rep. 2025; 15(1):4138.
PMID: 39900983 PMC: 11790876. DOI: 10.1038/s41598-025-88840-5.
Zhang M, Xue T, Fei X, Zhang Y, Luo Y, Ru Y Clin Exp Immunol. 2024; 218(2):199-212.
PMID: 38938103 PMC: 11482546. DOI: 10.1093/cei/uxae052.
Yang S, Guo J, Kong Z, Deng M, Da J, Lin X J Transl Med. 2024; 22(1):10.
PMID: 38167131 PMC: 10763396. DOI: 10.1186/s12967-023-04835-8.
Mende C, Samarakoon R, Higgins P Am J Nephrol. 2023; 54(1-2):50-61.
PMID: 36682353 PMC: 10273909. DOI: 10.1159/000528783.
Li Z, Zhou K, Chen F, Shang F, Wu M Int J Ophthalmol. 2022; 15(8):1221-1230.
PMID: 36017049 PMC: 9358189. DOI: 10.18240/ijo.2022.08.01.